Surviving triple-negative breast cancer

October 18, 2012

SURVIVING TRIPLE-NEGATIVE BREAST CANCER: Hope, Treatment, and Recovery by Patricia Prijatel is exactly that--an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis. "The book you are holding is my attempt to share what I have learned so you do not have to start from square one as I did," Prijatel writes, "Through education, I have learned how to help myself, how to keep myself focused on health and not fear. I hope that reading this book does the same for you." SURVIVING TRIPLE-NEGATIVE BREAST CANCER delivers research-based information on the biology of TNBC; the role of genetics, family history, and race; how to navigate treatment options; and a plethora of strategies to reduce the risk of recurrence, including diet and lifestyle changes.

Prijatel provides a fact-filled guide to understanding a pathology report and a vast array of scientific studies. Woven throughout the book are stories of women who have faced TNBC. These are mothers, wives, daughters, and sisters who went through a variety of medical treatments and then got on with life--one competes in triathlons, two had babies after being treated with chemo, one got remarried in her 50s, and one just celebrated the 30th birthday of the son she was nursing when she was diagnosed. These stories provide inspiration and a sense of camaraderie throughout the book, consistently reminding readers that this is a disease that others have fought and won.

Topics for discussion include:Writing with honesty and humor, Prijatel delivers an inspiring message--that TNBC is a disease to take seriously, with proper and occasionally aggressive treatment, but it is not automatically a killer. Most women diagnosed with the disease do survive. SURVIVING TRIPLE-NEGATIVE BREAST CANCER is a roadmap for women who want to be empowered through their treatment and recovery.
-end-
About the author: Patricia Prijatel, E.T. Meredith Distinguished Professor Emerita at Drake University, has helped educate, motivate, support, and challenge people for the better part of three decades. She is a nationally published magazine writer, an award-winning teacher, and a well-respected writing coach. Her "Positives About Negative" blog has reached more than 100,000 readers and is one of the few sites that deals specifically with triple negative breast cancer.

SURVIVING TRIPLE-NEGATIVE BREAST CANCER:
Hope, Treatment, and Recovery
by Patricia Prijatel, with a Foreword by Carol Scott-Conner, will be published in hardcover
by Oxford University Press on October 11, 1012
ISBN13: 9780195387629 -- ISBN10: 0195387627
$27.95 -- 248 pages

CONTACT: Tara Kennedy, 212.726.6258 or tara.kennedy@oup.com

"Prijatel's journalistic skills are evident in her fluid prose and the detail with which she lays out the specifics of TNBC . . . She states her goal here is to 'inform, educate, calm, and encourage.' She does so in fine form. Highly recommended."
--Library Journal, starred reviewSURVIVING TRIPLE-NEGATIVE BREAST CANCER
Hope, Treatment, and Recovery
By Patricia Prijatel
(Oxford | October 11, 2012 | ISBN13: 9780195387629 | $27.95 | 248 pages

Oxford University Press

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.